Okano N, Sakamaki K, Mie T, Watanabe K, et al. Outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in patients with early recurrent pancreatic cancer after adjuvant S-1 treatment: A propensity score-matched analysis. Pancreatology 2025 Aug 30:S1424-3903(25)00591-5. doi: 10.1016/j.pan.2025.
PMID: 40908168